The Journal/Weight Loss

Benefits of Semaglutide vs Tirzepatide for Weight Loss

Semaglutide acts on one receptor. Tirzepatide acts on two. Here is what that difference means in practice, and how a clinician picks between them.

Kris CutajAugust 8, 20255 min read

Medically reviewed by Dr. Erald Lula, MD, MPH · Triple Board-Certified · Internal Medicine, Obesity Medicine, Lifestyle Medicine

A clean side-by-side editorial composition with sage, berries, a leather notebook and tea, a thoughtful comparison.

Semaglutide acts on one receptor, GLP-1. Tirzepatide acts on two, GIP and GLP-1. That is the whole difference in a sentence, and it is why tirzepatide is often chosen for patients pursuing the largest reduction or those who plateaued on a GLP-1 alone, while semaglutide is the more common starting point. Both are once-weekly subcutaneous injections, both titrate slowly, and both need provider supervision.

At NuHealth the compounded semaglutide program starts at $125 a month and compounded tirzepatide at $265 a month. The table below compares them row by row. The rest of the article explains how a clinician actually picks between the two.

Semaglutide vs. Tirzepatide at a glance

If you're skimming for the short answer, here is the comparison side-by-side. The rest of the article walks through each row in depth, including the side-effect profile and how your clinician picks between them.

FactorSemaglutideTirzepatide
Drug classGLP-1 receptor agonistDual GIP + GLP-1 receptor agonist ("twincretin")
How it worksMimics the GLP-1 satiety hormone; slows gastric emptying; supports glycemic controlActs on both the GLP-1 and GIP pathways for a stronger combined appetite and metabolic effect
Dosing scheduleOnce-weekly subcutaneous injection, gradual dose titrationOnce-weekly subcutaneous injection, gradual dose titration
Common side effectsMild nausea (especially weeks 1–2), occasional GI upset; usually improves with titrationSimilar profile to semaglutide; some patients see slightly more pronounced GI effects from the GIP arm
Who it's often picked forPatients newer to GLP-1 therapy, or those who want a lower starting price pointPatients pursuing the largest possible body-weight reduction, or those who plateaued on a GLP-1 alone
NuHealth compounded starting price$125 / month$265 / month

NuHealth prescribes per-patient compounded formulations of semaglutide and tirzepatide, prepared by a state-licensed 503A pharmacy. Compounded medications are not FDA-approved finished products and are not interchangeable with any brand-name product. Individual results vary.

The Science Behind the Success

The two may seem similar on the surface, but their mechanisms of action set them apart. Both belong to a class of drugs known as incretin mimetics, which mimic hormones naturally produced in your gut.

Semaglutide's Mechanism: The GLP-1 Maestro

Semaglutide is a selective glucagon-like peptide-1 (GLP-1) receptor agonist. When you eat, your gut releases the GLP-1 hormone, and semaglutide mimics this hormone with a much longer-lasting effect.

  • Appetite Suppression: Acts on the parts of your brain that regulate hunger, making you feel fuller, sooner.
  • Delayed Gastric Emptying: Slows down the rate at which food leaves your stomach, prolonging the feeling of fullness.
  • Insulin and Glucagon Regulation: Enhances insulin secretion when blood sugar is high and reduces glucagon production.

Tirzepatide's Dual-Action Approach: The "Twincretin"

Tirzepatide is a more advanced medication, often referred to as a "twincretin" because it is a dual GIP and GLP-1 receptor agonist. It targets both the GLP-1 pathway (like semaglutide) and another hormone called glucose-dependent insulinotropic polypeptide (GIP). That dual action targets both the GLP-1 and GIP pathways for a combined effect on appetite and metabolism.

How They Work: A Visual Guide

Semaglutide (Single Action)

GLP-1

Reduces
Appetite

Slows
Digestion

Tirzepatide (Dual Action)

GLP-1 GIP

Enhanced
Appetite
Reduction

Slows
Digestion

How your provider chooses

Both medications work through the GLP-1 pathway (tirzepatide also acts on GIP). Which one fits you depends on your health history, tolerance, and goals — something your NuHealth provider reviews with you directly. Individual results vary.

Safety, Side Effects & Broader Health Benefits

Common Side Effects

The most common side effects for both are gastrointestinal (nausea, diarrhea, vomiting), are generally mild to moderate, and tend to occur most often during dose escalation. For most people, these side effects lessen significantly as their bodies adjust.

Cardiovascular Health: A Crucial Consideration

Cardiovascular effects of GLP-1 medications are an area of ongoing research; your provider can discuss what is relevant to your health profile.

The Practical Side: Cost, Coverage & Accessibility

The decision to start a new medication is also a financial one. Both medications have high retail prices without insurance, often exceeding $1,000 for a 28-day supply. Insurance coverage is highly variable and navigating it can be a complex puzzle. Check with your insurance provider and look into patient assistance programs from the pharmaceutical companies.

Making the Right Choice For You

There is no one-size-fits-all answer. The choice is a personal one that should be made in close consultation with your healthcare provider. This summary table can help you discuss the options with your doctor.

FeatureSemaglutideTirzepatide
MechanismGLP-1 Agonist (Single-action)GIP & GLP-1 Agonist (Dual-action)
Side EffectsMainly mild-to-moderate GISimilar, may be slightly more pronounced
Cost & CoverageHigh cost; potentially broader coverageHigh cost; coverage is growing

Who is Semaglutide Best For?

Patients who prefer a GLP-1 medication with extensive real-world use, or who are newer to this class of therapy. Your provider can discuss whether it fits your health profile.

Who is Tirzepatide Best For?

Patients who are otherwise healthy, can tolerate the potential gastrointestinal side effects, and want to discuss a dual GIP/GLP-1 option with their provider.

Conclusion & Next Steps

"Navigating this journey has taught me that the 'right' medication is not about a ranking; it's about a match. The right medication is the one that aligns with your specific health needs, lifestyle, and goals."

Both semaglutide and tirzepatide are meaningful options in the medical management of weight. Each works a little differently, and the better fit depends on your individual health needs, tolerance, and goals.

Your next step is simple but crucial:

Talk to your doctor.

They can help you weigh the benefits and risks of each medication, assess your insurance coverage, and create a personalized plan that sets you up for lasting success.